Editorial Board
Pharmacognosy Communications is guided by an independent international board. All submissions are handled by a section editor with no conflict of interest and reviewed under a double-anonymized policy.
Dr. Ian Cock
University of Tokyo, Japan
Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome. Editorial correspondence and appeals may be addressed to the Editor-in-Chief through the submission system.
Senior Editorial Team
3 membersSets editorial policy, arbitrates appeals and oversees the double-anonymized review process.
- Deputy Editor
Leila Fischer
KAUST, Saudi Arabia
- Deputy Editor
Pieter Delgado
Seoul National University, South Korea
- Ethics & Integrity Editor
Sofia Iyer
Technische Universität München, Germany
Research integrity, retractions
Associate Editors
0 membersOne handling editor per section, responsible for reviewer selection and decisions.
Advisory Board
Serving on the board
Associate editors serve renewable three-year terms. Nominations, including self- nominations from active reviewers of Pharmacogn. Commn., are reviewed twice a year by the senior editorial team.